Adicon Holdings (HKSE:09860) ROCE % : 0.00% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Adicon Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.00%.

Adicon Holdings ROCE % Historical Data

The historical data trend for Adicon Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings ROCE % Chart

Adicon Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROCE %

22.04

25.64

40.90

16.49

Adicon Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			-	49.58	35.99	15.17	-

Adicon Holdings ROCE % Calculation

Adicon Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	476.546	/	( ( (5420.793 - 2700.699)	+	(4980.564 - 1921.789) )	/ 2 )
	=	476.546	/	( (2720.094	+	3058.775)	/ 2 )
	=	476.546	/	2889.4345
	=	16.49 %

Adicon Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	0	/	( ( (5202.238 - 2225.2)	+	(4980.564 - 1921.789) )	/ 2 )
	=	0	/	( ( 2977.038	+	3058.775 )	/ 2 )
	=	0	/	3017.9065
	=	0.00 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Adicon Holdings (HKSE:09860) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Adicon Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (HKSE:09860) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ADCNF:USA

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Adicon Holdings (HKSE:09860) Headlines

No Headlines